DCs are recruited by releasing GM-CSF from the hydrogel, thereby providing a fully personalized tumor antigen repertoire, exhibiting excellent tumor-suppressive effects in postoperative tumor models [210]. This evidence concerns the gene CSF2 and neoplasm.